Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Lonza's Early Development Services Offering Expanding Into North America
Lonza has announced plans to establish a new laboratory in Cambridge, Massachusetts US, in an effort to broaden the scope of its Early Development Services EDS in North America The nearby Boston biotech communitys 17,000 square foot centre broadens Lonzas current EDS product range
Lilly Plans to invest US $450 million at a US Manufacturing Site
Eli Lilly plans to invest US $450 million in a facility in the Research Triangle Park area of the United States, to expand its manufacturing capabilities To meet the growing demand for Lillys incretinbased diabetes treatments, the expansion includes more parenteral filling, device assembly, and packaging capacity
AtomVie Starts Construction of a New Radiopharmaceutical CDMO Facility in Canada
AtomVie Global Radiopharma Inc AtomVie has started the construction of a new radiopharmaceutical stateoftheart facility in Hamilton, Ontario, Canada AtomVies new 64,000 square foot facility, which is currently situated on the grounds of McMaster University, will be used exclusively for the high volume clinical and commercial
Agilent Technologies Invests US $725 million on Manufacturing Facility Expansion in USA
Agilent Technologies invested $725 million, to double the facility in Frederick, Colorados manufacturing capability for therapeutic nucleic acids A increasing number of diseases, including cancer, cardiovascular disease, rare diseases, and infectious diseases, require the use of active pharmaceutical
Ardena to Expand Manufacturing Facility in Sweden
Ardena is nearly tripling the size of its Swedish facility, as part of a US $ 37 million investment across its European operations The company is making investments in the production of drug substances in Sdertlje in order to increase capacity These include a new production line, a larger preparative High
Thermo Fisher Scientific Invests US $59 million for Laboratory Expansion in USA
Thermo Fisher Scientific has invested US $ 59 million for the expansion of its laboratory operations in Highland Heights, Kentucky, USA With this expansion, Thermo Fischer will be able to deliver lifechanging medicines to patients The current facility, at 71,600sqft, will grow to 114,000sqft and be completed in stages by the end of 2024
Almac Group Invests US $65 million for Clinical Facility Expansion in the USA
In order to expand its clinical supply operations, Almac Group invested US $65 million at the companys North American headquarters in Souderton, Pennsylvania With additional cold and ultralow storage and justintime processing capabilities, the 100,000 ft2 facility will increase the facilitys clinical capacity
Synthego Begins Work on a Manufacturing Facility in the USA
Synthego has started work on a 20,000squarefoot manufacturing facility in the USA The facility, which will be situated in the San Francisco Bay region, will enable the company to enhance the manufacturing of its gene editing tools by expanding the Halo platform
WuXi STA Begins Pharmaceutical Manufacturing Facility Construction in USA
WuXi STA has begun construction of a new 190acre pharmaceutical manufacturing campus in Middletown, Delaware, in the United States This location will be WuXi STAs second in the country, providing increased flexibility and capacity to meet the demands of clients in the US and beyond
Catalent Invests US$ 2.2 million for Clinical Supply Facility in Singapore
Catalent invested US$22 million for the expansion of its clinical supply facilities in Singapore The investment will allow the installation of 35 new freezers for ultralow temperature ULT storage, expanding the sites footprint by over 20 to 31,000 square feet
